
GC31599
Soluble epoxide hydrolase inhibitor
Also known as N-[[4-cyano-2-(trifluoromethoxy)phenyl]methyl]-2-(2,2-difluoroethyl)-3-oxo-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide
Soluble epoxide hydrolase inhibitor is an inhibitor of soluble epoxide hydrolase, and inhibits human soluble epoxide hydrolase (h-sEH) with pIC50 of 8·4, extracted from patent WO 2010096722 A1, example 57
ChemicalCAS1241826-88-9MW441.31FormulaC18H12F5N5O3
- CAS number
- 1241826-88-9
- Molecular weight
- 441.31
- Formula
- C18H12F5N5O3
- Solubility
- Soluble in DMSO
- InChIKey
- ZXXHBMCIQXGVRD-UHFFFAOYSA-N
- Catalogue number
- GC31599
- Brand
- GLPBIO
Computed properties PubChem CID 46861626 · XLogP 2.5 · TPSA 98 Ų · H-bond donors 1
- XLogP
- 2.5
- TPSA
- 98 Ų
- H-bond donors
- 1
- H-bond acceptors
- 10
- Rotatable bonds
- 6
- Heavy atoms
- 31
SMILES C1=CC(=C(C=C1C#N)OC(F)(F)F)CNC(=O)C2=CN3C(=NN(C3=O)CC(F)F)C=C2
Computed descriptors from PubChem (CID 46861626), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il